Each marker below carries its technical name, what it measures in plain language, the limits of what it can tell you, and the nutrients known to move it. Where a framework and mainstream practice disagree, both views are shown rather than one being hidden.
Iron Panel (Serum Iron, Ferritin, TIBC, Transferrin Saturation)
Cellular Six: ExchangeThis marker sits in Exchange -- moving iron across boundaries and handing it between carriers.
Serum iron is circulating iron at the moment of the draw; ferritin reflects iron stores (but is also an acute-phase inflammatory protein); TIBC reflects how much transferrin (the iron-carrier protein) is available; transferrin saturation is the percentage of that capacity currently in use.
Typical range: Ferritin ~15-150 ng/mL (women), ~20-250 ng/mL (men), lab-dependent; serum iron ~60-170 mcg/dL; saturation 20-50%; TIBC 250-450 mcg/dL (conventional ranges, consistent with mainstream lab medicine).
How it is used clinically
Ferritin as a positive acute-phase reactant rising independent of iron status is well established [SOLID] -- this is exactly why mainstream labs pair ferritin with CRP/iron saturation rather than reading it alone. "Anemia of inflammation/chronic disease" is a recognized mainstream diagnosis, and its mechanism (hepcidin-driven iron sequestration in macrophages during inflammation) is well described, but this is attributed to hepcidin/inflammatory signaling, not primarily to copper-ceruloplasmin insufficiency. True tissue iron overload in humans is a well-characterized condition (hereditary hemochromatosis, most often HFE gene mutations, or secondary overload from repeated transfusions) that is diagnosed via genetic testing and/or elevated transferrin saturation and ferritin together -- not inferred from "normal" labs. Hemosiderin itself is a real, recognized iron-storage form (seen on biopsy/imaging in genuine overload states), but using it as a routinely-tested marker of subclinical "hidden" overload in people with normal iron panels is not standard practice.
What this framework claims
Robbins argues "ferritin is nothing, hemosiderin is everything" -- that a "normal" or even low ferritin doesn't rule out tissue iron overload, because without adequate ceruloplasmin ferroxidase activity, iron can't be safely loaded into ferritin's storage shell and instead degrades into hemosiderin, a less-regulated iron-storage form that RCP treats as a marker of chronic iron mishandling. RCP also argues that a large share of "anemia of chronic disease/inflammation" is actually a copper-ceruloplasmin problem (iron stuck in tissue, unable to move) rather than a true iron shortage, and warns against iron supplementation in this pattern because it can add fuel to an already-dysregulated system.
Nutrients that move it
- Copper/ceruloplasmin (mechanistic support for RCP's model)emerging -- in mice engineered to lack both multicopper ferroxidases (hephaestin and ceruloplasmin), animals developed severe anemia and low serum/spleen iron *alongside* iron overload in the liver, heart, kidney, and duodenum -- a real, published finding that does partially mirror RCP's "low serum iron with tissue overload" picture. (cite: Fuqua BK et al., Cellular and Molecular Gastroenterology and Hepatology, 2018) A separate mouse study found dietary copper deficiency alone (not full ferroxidase gene knockout) caused anemia, duodenal hypoxia, and altered iron-absorption gene expression. (cite: Matak P et al., PLOS ONE, 2013) **Important caveat:** these are severe genetic-knockout or induced-deficiency animal models, not evidence that ordinary, mild nutritional copper insufficiency produces this pattern in humans with normal genes -- extrapolating from double-knockout mice to "most fatigued adults have this" is RCP's leap, not something demonstrated in human trials.
- Vitamin Csolid -- enhances non-heme iron absorption; meta-analyses of iron-deficiency-anemia trials show a small but real boost to hemoglobin/ferritin when added to iron supplementation. (cite: systematic review/meta-analysis, ASH Blood Vessels Thrombosis & Hemostasis, 2024)
- Riboflavin (B2)emerging -- RCP claims B2 is required to mobilize iron out of storage. There is real, if limited, supporting evidence: riboflavin-dependent enzymes participate in reductively releasing iron from ferritin, riboflavin deficiency impairs iron mobilization in animal models, and population studies link inadequate riboflavin intake to higher anemia risk; a supplement trial in mildly anemic populations showed riboflavin enhanced the hemoglobin response to standard iron treatment. This is real, but modest, supportive evidence -- not proof that B2 is a primary driver of most iron-panel abnormalities. (cite: Nutrition Reviews, 2023; Jiangsu Nutrition Study, PMC3923059)
Food first: Heme iron (red meat, poultry, fish) is more bioavailable than plant iron; pair plant iron with vitamin C; ensure adequate riboflavin (dairy, eggs, leafy greens, organ meats) and copper (liver, shellfish) as supporting cofactors.
When to see someone: Iron overload -- from hereditary haemochromatosis or from sustained over-supplementation -- causes irreversible damage to the liver, heart and pancreas, so a confirmed deficiency should come before iron is added. A genuinely abnormal panel, particularly a raised transferrin saturation with a raised ferritin, warrants a standard workup including consideration of HFE genetic testing rather than a self-directed mineral protocol. Ferritin is always read alongside CRP.
Read the studies on Iron Panel (Serum Iron, Ferritin, TIBC, Transferrin Saturation)Serum Copper
Cellular Six: ExchangeThis marker sits in Exchange -- moving iron across boundaries and handing it between carriers.
Total circulating copper, of which roughly 95% is normally bound to ceruloplasmin and about 5% is loosely bound to albumin and small peptides (the "free" or "non-ceruloplasmin-bound" fraction).
Typical range: Roughly 70-140 mcg/dL for men, 80-155 mcg/dL for women (ranges vary somewhat by lab/method).
How it is used clinically
Serum copper is used mainly to screen for overt copper deficiency (rare, usually from malabsorption, bariatric surgery, or chronic excess zinc intake) or Wilson's disease/copper overload, alongside ceruloplasmin. It's a recognized positive acute-phase reactant [SOLID] -- it rises with inflammation, infection, pregnancy, and estrogen (including oral contraceptives), which is a real and important interpretive caveat but is a different mechanism than RCP's "bioavailability" framing.
What this framework claims
Robbins argues total serum copper alone is close to meaningless, because it doesn't tell you how much of that copper is actually "bioavailable" -- i.e., properly incorporated into functional ceruloplasmin versus floating "unbound." RCP treats a "normal" total copper as potentially masking a functional copper deficiency.
Nutrients that move it
- Zinc antagonismsolid -- chronic high-dose zinc intake (>40 mg/day) induces intestinal metallothionein, which binds copper and blocks its absorption; this is a well-documented, mainstream-recognized cause of copper deficiency, not an RCP-specific claim.
- Retinol/vitamin Aemerging -- see Ceruloplasmin section below; retinoic acid can induce ceruloplasmin gene expression in cell models, which is the mechanistic basis for RCP's copper + retinol pairing, but this is early-stage/cell-culture evidence, not a clinical trial in humans with "low energy."
Food first: Beef/chicken liver, oysters and shellfish, cacao are copper-dense whole foods RCP favors; standard nutrition guidance agrees these are good copper sources for people with confirmed low intake or deficiency.
When to see someone: Copper has a genuinely narrow window in both directions. Overload is Wilson's disease, a genetic condition causing serious liver and neurological damage that needs hepatology or genetics management. A raised serum copper on its own should prompt checking ceruloplasmin and ruling out inflammation, pregnancy or oestrogen therapy -- all of which raise it -- before it is read as dysregulation.
Read the studies on Serum CopperSerum Ceruloplasmin
Cellular Six: ExchangeThis marker sits in Exchange -- moving iron across boundaries and handing it between carriers.
The major copper-transport protein made in the liver; it carries the large majority of circulating copper and functions as a ferroxidase enzyme, oxidizing ferrous iron (Fe2+) to ferric iron (Fe3+) so iron can bind to transferrin and be moved and stored safely. This ferroxidase role is well-established, mainstream biochemistry. **[SOLID]** (cite: Vashchenko G, MacGillivray RT, Nutrients, 2013; StatPearls, NCBI Bookshelf)
Typical range: Roughly 20-40 mg/dL in most adult reference ranges (some labs cite 27-37 mg/dL); varies by assay.
How it is used clinically
Ceruloplasmin is primarily used clinically to screen for Wilson's disease (characteristically low) and to help confirm copper deficiency; it is also a well-established positive acute-phase reactant [SOLID] -- levels rise during infection, inflammation, tissue injury, and pregnancy/estrogen exposure. This matters directly for RCP's framing: a "normal" or even elevated ceruloplasmin during an inflammatory state doesn't necessarily mean someone is copper-replete and metabolically healthy, and a "low-normal" reading isn't automatically a sign of an underlying, correctable "bioavailable copper" deficiency the way RCP frames it. (cite: StatPearls, NCBI Bookshelf; Inflammation Research review)
What this framework claims
Robbins treats ceruloplasmin as the single most important lab in the protocol -- low or "sub-optimal" ceruloplasmin is, in RCP's model, the functional bottleneck that lets iron and copper go "unbound" and drive oxidative stress and fatigue. RCP asserts ceruloplasmin synthesis specifically requires adequate magnesium plus retinol (true vitamin A), and pushes cod liver oil and magnesium supplementation on this basis from day one of the protocol.
Nutrients that move it
- Coppersolid -- copper is ceruloplasmin's direct structural substrate (six copper atoms per molecule); without adequate copper, ceruloplasmin cannot be made, regardless of other nutrient status.
- Retinol/vitamin Aemerging -- retinoic acid (a vitamin A metabolite) has been shown to induce ceruloplasmin gene expression and rescue ceruloplasmin secretion specifically in Wilson's-disease-patient-derived liver cells in a lab-dish (in vitro) model. (cite: PMC9616579) This gives RCP's retinol-ceruloplasmin pairing a real mechanistic basis, but it's disease-specific, cell-culture evidence -- it does not show that giving healthy or mildly fatigued people extra retinol meaningfully raises their ceruloplasmin or resolves symptoms.
- Magnesium (RCP assertion, not established in peer-reviewed literature) -- Robbins states magnesium is directly required for ceruloplasmin synthesis. Magnesium's broad role as a cofactor in protein synthesis and hundreds of enzymatic reactions is [SOLID], well-documented physiology, but a specific, dedicated magnesium-to-ceruloplasmin-synthesis pathway was not found in the peer-reviewed literature searched for this file. This specific claim should be treated as RCP's extrapolation from magnesium's general biochemical importance, not a demonstrated mechanism.
Food first: Copper-rich foods (liver, shellfish) support the substrate side; retinol-rich foods (liver, egg yolk, dairy fat, cod liver oil) are the RCP-favored vitamin A source, on the theory that preformed retinol (not beta-carotene) is what's needed.
When to see someone: A low ceruloplasmin together with a high non-ceruloplasmin-bound ("free") copper and/or neurological or liver symptoms warrants a Wilson's disease workup with a specialist -- this is a serious genetic condition, not something to self-manage with a mineral protocol.
Read the studies on Serum CeruloplasminCopper:Ceruloplasmin Ratio ("Bioavailable"/Unbound Copper)
Cellular Six: ExchangeThis marker sits in Exchange -- moving iron across boundaries and handing it between carriers.
RCP calculates a ratio between total serum copper and ceruloplasmin (or ceruloplasmin-bound copper) to estimate how much circulating copper is "unbound"/not carried by ceruloplasmin. The closest validated mainstream analog is **non-ceruloplasmin-bound copper (NCC)**, calculated as total serum copper minus the copper accounted for by measured ceruloplasmin, used in specialist hepatology/Wilson's-disease practice.
Typical range: There is no widely recognized, standardized "normal" copper:ceruloplasmin ratio in mainstream lab medicine. For the related NCC calculation used in Wilson's disease diagnostics, values above roughly 25 mcg/dL (with a low ceruloplasmin) are suggestive of Wilson's disease, but cutoffs vary meaningfully by lab and assay and are not standardized for general population screening. (cite: Journal of Trace Elements in Medicine and Biology, non-ceruloplasmin-bound copper across laboratories)
How it is used clinically
The underlying concept -- that non-ceruloplasmin-bound copper is the more redox-active, potentially harmful fraction -- is real and grounded in legitimate laboratory medicine [SOLID for the concept itself], but its clinical use is almost entirely confined to diagnosing and monitoring Wilson's disease and severe copper-overload states in specialist settings, not as a general wellness or fatigue marker in people with normal copper-handling genetics. **[CONTESTED]** -- extending this calculation to a general population as a routine "bioavailability" wellness marker is RCP's own application and is not an established or validated use of the test. (cite: ScienceDirect, non-ceruloplasmin-bound copper analytical challenges)
What this framework claims
RCP holds that in a healthy person nearly all copper should be ceruloplasmin-bound (roughly a 1:1 relationship), and that a meaningfully "unbound" fraction represents unregulated, pro-oxidant "toxic copper" -- distinct from and much more common than clinical Wilson's disease -- that RCP considers a driver of everyday fatigue and oxidative-stress symptoms.
Food first: No dedicated evidence-based nutrition protocol exists for "lowering the unbound copper fraction" outside the Wilson's disease context; general copper/retinol/magnesium sufficiency is RCP's proposed lever.
When to see someone: A genuinely elevated unbound/free copper fraction, especially with low ceruloplasmin, is a marker of a serious medical condition (Wilson's disease) requiring a hepatologist or geneticist -- a self-calculated ratio from routine labs should never be used to diagnose or rule out Wilson's disease, and should not delay a proper specialist workup if clinically suspected.
Read the studies on Copper:Ceruloplasmin Ratio ("Bioavailable"/Unbound Copper)Magnesium RBC (Red Blood Cell Magnesium)
Cellular Six: TransformThis marker sits in Transform -- the cofactors enzymes need to turn fuel into usable energy.
Magnesium concentration inside red blood cells, which -- because RBCs live about 120 days -- reflects a longer-term, more stable snapshot of intracellular magnesium status than serum magnesium, which represents less than 1% of total body magnesium and can shift acutely with stress hormones. This physiological rationale (serum magnesium as a poor proxy for tissue status) is well-supported. **[SOLID]**
Typical range: Roughly 4.0-6.8 mg/dL depending on the lab (e.g., Quest ~4.0-6.4 mg/dL, LabCorp ~4.2-6.8 mg/dL).
How it is used clinically
RBC magnesium is a legitimate research and specialist-clinical tool, and there is real physiological support for the idea that serum magnesium can be misleading: in one classic study, intravenous epinephrine significantly lowered serum magnesium without changing free intracellular RBC magnesium (measured by NMR), showing that acute stress can drop serum readings without reflecting true tissue depletion. (cite: Joborn H et al., PMID 2187026) That said, RBC magnesium is not part of routine primary-care panels, and clinical chemistry does not treat it as a perfected "gold standard" -- there's ongoing debate about which test (serum ionized magnesium, total serum magnesium, RBC magnesium, or a magnesium-loading/retention test) best reflects true body magnesium status; RBC magnesium is a reasonable, evidence-supported option, not a settled superior standard the way RCP sometimes implies. **[EMERGING/SOLID, mixed]**
What this framework claims
RCP considers RBC magnesium a meaningfully better status marker than serum magnesium and central to the whole protocol, targeting the upper part of the reference range or above.
Nutrients that move it
- Magnesium and ATP/enzymatic functionsolid -- magnesium is a required cofactor for several hundred enzymatic reactions and stabilizes the negative charges on ATP's phosphate groups, a foundational and uncontested piece of biochemistry. (cite: de Baaij JH, Hoenderop JG, Bindels RJ, Clinical Kidney Journal, 2012)
- Magnesium and blood pressuresolid -- meta-analysis of 38 RCTs found magnesium supplementation modestly lowers blood pressure, more so in hypertensive/hypomagnesemic people. (cite: Hypertension journal meta-analysis, 2025 -- see Studies library, Vitamins/Minerals section)
- Magnesium and glycemic controlemerging -- modest HbA1c/glucose improvement in magnesium-deficient or diabetic populations (see Function Health panel file for full citation detail).
Food first: Leafy greens, nuts, seeds, legumes, whole grains, dark chocolate; supplemental forms like magnesium glycinate or citrate are generally better tolerated than oxide.
When to see someone: Anyone with reduced kidney function (low eGFR) needs medical guidance before supplementing magnesium at RCP-recommended doses -- magnesium is renally cleared and can accumulate to dangerous levels in kidney disease. High-dose oral magnesium commonly causes diarrhea before anything more serious in people with normal kidneys.
Read the studies on Magnesium RBC (Red Blood Cell Magnesium)High-Sensitivity C-Reactive Protein (hs-CRP)
Cellular Six: MaintainThis marker sits in Maintain -- the cleanup and defence system, and whether it is switched on.
A liver-produced marker of systemic inflammation, standard in cardiology risk assessment.
Typical range: <1.0 mg/L low cardiovascular risk, 1.0-3.0 average, >3.0 high risk (standard AHA/CDC cutoffs).
How it is used clinically
This particular use -- pairing CRP with ferritin to sort out whether ferritin is elevated due to inflammation versus true iron stores -- is actually standard, mainstream laboratory-medicine practice, not an RCP-specific innovation. **[SOLID]** Where RCP diverges is in attributing the underlying inflammation itself primarily to copper/iron/magnesium mineral dysregulation rather than the broader, well-established list of drivers (diet, adiposity, infection, autoimmune activity, smoking, poor sleep, etc.).
What this framework claims
RCP uses hs-CRP as a companion marker to the iron panel -- specifically to help decide whether an elevated or "normal" ferritin is being driven by inflammation (masking a true iron problem) rather than genuine iron stores, and treats persistent inflammation itself as a downstream sign of the mineral-dysregulation/oxidative-stress model.
Food first: Mediterranean-pattern eating, weight management, smoking cessation -- these move hs-CRP more reliably than any single mineral intervention.
When to see someone: hs-CRP rises with any acute infection, injury, or recent exercise/dental work -- a single elevated reading isn't meaningful in isolation.
Read the studies on High-Sensitivity C-Reactive Protein (hs-CRP)Zinc and the Zinc:Copper Ratio
Cellular Six: ExchangeThis marker sits in Exchange -- moving iron across boundaries and handing it between carriers.
Serum zinc reflects circulating zinc status (an imperfect marker, since most zinc is intracellular); the zinc:copper (or copper:zinc) ratio compares the two minerals, which compete for absorption via intestinal metallothionein.
Typical range: Serum zinc roughly 60-120 mcg/dL. A reference interval for the plasma copper/zinc ratio of about 0.54-1.68 has been established in healthy women of childbearing age; RCP and some functional-medicine sources cite a narrower "optimal" ratio of roughly 0.7-1.0, which is an opinion range, not a diagnostic cutoff. (cite: Nutrients, 2021, PMC7999022)
How it is used clinically
The zinc-copper antagonism itself (high-dose zinc inducing metallothionein, which binds and blocks copper absorption) is well-established, mainstream physiology [SOLID], and is the basis of a recognized clinical entity: zinc-induced copper deficiency, usually from chronic high-dose zinc supplementation or denture-cream misuse, causing myeloneuropathy and anemia. Using the specific ratio as a routine wellness marker for anxiety, mood, or hormone symptoms in the general population is **[CONTESTED]** -- reference intervals for the ratio exist, but tying specific ratio bands to those symptoms hasn't been established in controlled studies.
What this framework claims
RCP watches this ratio closely, treating a copper-dominant or zinc-dominant imbalance as a driver of symptoms (copper excess linked to anxiety/estrogen dominance in RCP writing; zinc excess linked to blunted immunity and copper deficiency).
Nutrients that move it
- Zinc and immune functionsolid -- zinc lozenges/supplementation shortens common cold duration in meta-analysis (see Function Health panel file for citation).
Food first: Balance zinc-rich foods (oysters, red meat, seeds) with copper-rich foods (liver, shellfish, cacao) rather than supplementing either in isolation long-term without monitoring.
When to see someone: Chronic zinc supplementation above ~40 mg/day risks copper deficiency and its neurological/hematologic consequences; anyone on long-term zinc should have copper status periodically checked.
Read the studies on Zinc and the Zinc:Copper RatioWhole-Blood / Hair Mineral Analysis (HTMA)
Cellular Six: TransformThis marker sits in Transform -- the cofactors enzymes need to turn fuel into usable energy.
Hair tissue mineral analysis (HTMA) measures mineral and trace-element concentrations in a hair sample, marketed as a window into longer-term tissue mineral status; RCP sometimes references whole-blood or hair testing as a supplementary way to assess mineral patterns beyond a standard serum panel.
Typical range: No standardized reference ranges exist across labs; each commercial HTMA lab uses its own ranges and often its own proprietary "ratio" interpretive system.
How it is used clinically
HTMA's reliability is genuinely contested even outside RCP specifically. **[CONTESTED]** A landmark study sent split samples from a single healthy volunteer to six US commercial hair-testing labs and found more than 10-fold differences in reported concentrations for 12 different minerals between labs. (cite: JAMA, 2001, PMID 11150111) More recent work confirms that intra- and inter-laboratory reliability for HTMA remains inconsistent and heavily dependent on which lab and methodology is used, and correlation between hair mineral levels and actual serum/tissue status is weak to moderate for most minerals (hair zinc versus serum zinc correlates only weakly, for example). (cite: PMC3582931) HTMA is on firmer ground for detecting toxic heavy metals (lead, mercury, cadmium, arsenic), where peer-reviewed and CDC/ATSDR biomonitoring methods have more established validity -- but using it to diagnose "metabolic types," mineral-ratio-based disease patterns, or to guide RCP's specific mineral-dosing decisions is not supported by controlled clinical evidence.
What this framework claims
HTMA and mineral-ratio analysis are used by some RCP-adjacent practitioners to infer "oxidation type," adrenal/thyroid patterns, and mineral dysregulation not visible on standard blood work.
Food first: N/A.
When to see someone: Don't make major supplementation decisions (especially involving iron, copper, or high-dose minerals) based solely on an HTMA result -- confirm with standard serum/blood testing, since HTMA's inter-lab reliability for general mineral status is weak.
Read the studies on Whole-Blood / Hair Mineral Analysis (HTMA)Retinol (Vitamin A)
Cellular Six: BuildThis marker sits in Build -- the raw material for making and renewing structure.
Serum retinol reflects circulating, "storage-form" vitamin A status, though serum levels are homeostatically buffered and don't fall until liver stores are substantially depleted.
Typical range: Roughly 20-60 mcg/dL in most adult reference ranges (some labs cite 28-86 mcg/dL); levels at or below ~20 mcg/dL suggest moderate deficiency, ≤10 mcg/dL suggests severe deficiency.
How it is used clinically
Retinol's role in normal hematopoiesis (red blood cell production) and immune function is well-established [SOLID] mainstream nutrition science, and severe vitamin A deficiency is a recognized cause of anemia in deficient populations. Retinoic acid inducing ceruloplasmin expression has real in vitro support (see Ceruloplasmin section). Where mainstream and RCP diverge: RCP's claim that most people in food-secure countries are meaningfully retinol-deficient despite normal labs, and that this deficiency is a major driver of everyday fatigue, is **[CONTESTED]** -- overt vitamin A deficiency is uncommon in well-nourished populations, and there is no clinical trial showing that supplementing retinol above sufficiency in non-deficient adults improves fatigue or ceruloplasmin function.
What this framework claims
RCP holds that most people are functionally retinol-insufficient despite "normal" serum levels, that only preformed, animal-sourced retinol (not plant beta-carotene) can be efficiently used to build ceruloplasmin and support red blood cell production, and recommends cod liver oil from the start of the protocol on this basis, citing historical (19th-century) use of cod liver oil for anemia and mid-20th-century research on vitamin A deficiency and blood formation.
Food first: Liver, egg yolks, full-fat dairy, and (per RCP) cod liver oil are preformed-retinol sources; orange/yellow vegetables provide beta-carotene, a precursor the body converts to retinol at a variable and self-limiting rate.
When to see someone: Preformed vitamin A (retinol, as in cod liver oil and liver) has real toxicity risk that beta-carotene does not. Intakes above roughly 10,000 IU/day (3,000 mcg RAE) of preformed retinol during pregnancy are linked to increased birth-defect risk, with clearer teratogenic signal above 25,000-30,000 IU/day; a single very high acute dose (>100,000 IU) in early pregnancy is a recognized teratogenic risk. (cite: Rothman KJ et al., NEJM, 1995; EFSA Scientific Opinion, 2024) Pregnant or potentially pregnant women should not start high-dose cod liver oil or retinol supplementation without discussing dose with a clinician. Chronic high-dose preformed vitamin A in anyone can cause liver toxicity, bone pain, and headaches (hypervitaminosis A).
Read the studies on Retinol (Vitamin A)